Treatment of Challenging Macular Holes Using Plasma Rich in Growth Factors

PHASE2RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

December 31, 2023

Study Completion Date

August 1, 2024

Conditions
Macular Holes
Interventions
BIOLOGICAL

Plasma rich in growth factors ( PRGF )

"Plasma rich in growth factors (PRGF) is characterized by a moderate concentration of platelets, in the absence of leukocytes.~This absence of leukocytes is based on the fact that they synthesize matrix metalloproteinases, free radicals, and proinflammatory cytokines, which do not contribute and even impair the altered tissue regeneration"

Trial Locations (1)

Unknown

RECRUITING

Minia University Hospital, Minya

All Listed Sponsors
lead

Minia University

OTHER